Furthermore, many perfectly founded adverse prognostic markers, which includes U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, lost their negative result in clients treated with VO. The only factor that remained predictive of a shorter progression-no cost survival In this particular cohort of individuals was TP53 aberrations.112 Finally, the choi